/Is Buying InMode Ltd. (INMD) Here a Winning Strategy? (via Qpute.com)

Is Buying InMode Ltd. (INMD) Here a Winning Strategy? (via Qpute.com)


The stock of InMode Ltd. (NASDAQ:INMD) reached all time high today, Nov, 15 and still has $51.42 target or 4.00 % above today’s $49.44 share price. This indicates more upside for the $1.58B company. This technical setup was reported by Barchart.com. If the $51.42 PT is reached, the company will be worth $63.24M more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events.

The stock increased 7.71% or $3.54 during the last trading session, reaching $49.44. About 1.42 million shares traded or 38.56% up from the average. InMode Ltd. (NASDAQ:INMD) has 0.00% since November 15, 2018 and is . It has by 0.00% the S&P500.

InMode Ltd. (NASDAQ:INMD) Ratings Coverage

Among 4 analysts covering InMode (NASDAQ:INMD), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. InMode has $4500 highest and $2700 lowest target. $32.50’s average target is -34.26% below currents $49.44 stock price. InMode had 5 analyst reports since September 3, 2019 according to SRatingsIntel. As per Wednesday, November 6, the company rating was maintained by Robert W. Baird.

More notable recent InMode Ltd. (NASDAQ:INMD) news were published by: Benzinga.com which released: “61 Biggest Movers From Yesterday – Benzinga” on November 06, 2019, also Benzinga.com with their article: “30 Healthcare Stocks Moving In Friday’s Pre-Market Session – Benzinga” published on November 15, 2019, Nasdaq.com published: “Samsung, UAE funds lead $55 mln investment in quantum computing startup – Nasdaq” on October 22, 2019. More interesting news about InMode Ltd. (NASDAQ:INMD) were released by: Benzinga.com and their article: “Stocks That Hit 52-Week Highs On Monday – Benzinga” published on November 11, 2019 as well as Seekingalpha.com‘s news article titled: “NextCure down 53% premarket on NC318 data – Seeking Alpha” with publication date: November 11, 2019.

InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. The company has market cap of $1.58 billion. The firm offers minimally-invasive aesthetic medical products for procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It has a 50.55 P/E ratio. It also designs, develops, makes, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

.(tagsToTranslate)InMode Ltd.(t)InMode Ltd. – (NASDAQ:INMD)(t)NASDAQ:INMD(t)Gap(t)Chart Formation(t)Stock Pattern(t)Chart Pattern


This is a syndicated post. Read the original post at Source link .